| Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies MD Mattie, CC Benz, J Bowers, K Sensinger, L Wong, GK Scott, V Fedele, ... Molecular cancer 5, 1-14, 2006 | 1012 | 2006 |
| MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium F Schembri, S Sridhar, C Perdomo, AM Gustafson, X Zhang, A Ergun, J Lu, ... Proceedings of the National Academy of Sciences 106 (7), 2319-2324, 2009 | 525 | 2009 |
| Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis R Duttagupta, S DiRienzo, R Jiang, J Bowers, J Gollub, J Kao, K Kearney, ... PloS one 7 (2), e31241, 2012 | 126 | 2012 |
| Identification of methods for use of formalin-fixed, paraffin-embedded tissue samples in RNA expression profiling L Roberts, J Bowers, K Sensinger, A Lisowski, R Getts, MG Anderson Genomics 94 (5), 341-348, 2009 | 83 | 2009 |
| Rational probe optimization and enhanced detection strategy for microRNAs using microarrays LA Goff, M Yang, J Bowers, RC Getts, RW Padgett, RP Hart RNA biology 2 (3), 93-100, 2005 | 76 | 2005 |
| Evaluation of sense-strand mRNA amplification by comparative quantitative PCR LA Goff, J Bowers, J Schwalm, K Howerton, RC Getts, RP Hart Bmc Genomics 5, 1-9, 2004 | 68 | 2004 |
| Limited nutrient availability in the tumor microenvironment renders pancreatic tumors sensitive to allosteric IDH1 inhibitors A Vaziri-Gohar, J Cassel, FS Mohammed, M Zarei, JJ Hue, O Hajihassani, ... Nature Cancer 3 (7), 852-865, 2022 | 60 | 2022 |
| Unprecedently high targeting specificity toward lung ICAM-1 using 3DNA nanocarriers N Roki, Z Tsinas, M Solomon, J Bowers, RC Getts, S Muro Journal of Controlled Release 305, 41-49, 2019 | 27 | 2019 |
| Depletion of Myo/Nog cells in the lens mitigates posterior capsule opacification in rabbits J Gerhart, L Werner, N Mamalis, J Infanti, C Withers, F Abdalla, C Gerhart, ... Investigative Ophthalmology & Visual Science 60 (6), 1813-1823, 2019 | 18 | 2019 |
| Methods for detection of microrna molecules R Getts, J Kadushin, J Bowers US Patent App. 10/979,052, 2006 | 14 | 2006 |
| B-cell-targeted 3DNA nanotherapy against indoleamine 2, 3-dioxygenase 2 (IDO2) ameliorates autoimmune arthritis in a preclinical model LMF Merlo, J Bowers, T Stefanoni, R Getts, L Mandik-Nayak Clinical Pathology 13, 2632010X20951812, 2020 | 12 | 2020 |
| Brain-specific angiogenesis inhibitor 1 is expressed in the Myo/Nog cell lineage J Gerhart, J Bowers, L Gugerty, C Gerhart, M Martin, F Abdalla, ... PLoS One 15 (7), e0234792, 2020 | 10 | 2020 |
| A Novel 3DNA® Nanocarrier effectively delivers payloads to pancreatic tumors GA McCarthy, A Jain, R Di Niro, CW Schultz, W Jiang, CJ Yeo, J Bowers, ... Translational Oncology 32, 101662, 2023 | 4 | 2023 |
| A method to improve quantitative radiotracing‐based analysis of the in vivo biodistribution of drug carriers N Roki, M Solomon, L Casta, J Bowers, RC Getts, S Muro Bioengineering & Translational Medicine 6 (2), e10208, 2021 | 4 | 2021 |
| Tuning Design Parameters of ICAM-1-Targeted 3DNA Nanocarriers to Optimize Pulmonary Targeting Depending on Drug Type N Roki, M Solomon, J Bowers, L Getts, RC Getts, S Muro Pharmaceutics 14 (7), 1496, 2022 | 3 | 2022 |
| Methods, Reagents and Kits for Detection of Nucleic Acid Molecules RC Getts, J Kadushin, J Bowers US Patent App. 12/625,657, 2010 | 3 | 2010 |
| Sustained Release of Antibody-Conjugated DNA Nanocarriers from a Novel Injectable Hydrogel for Targeted Cell Depletion to Treat Cataract Posterior Capsule Opacification LL Osorno, RJ Mosley, PL Poley, J Bowers, G Gorski, J Gerhart, R Getts, ... Journal of Ocular Pharmacology and Therapeutics 38 (6), 404-411, 2022 | 2 | 2022 |
| Influence of RNA labeling on expression profiling of microRNAs JS Kaddis, DH Wai, J Bowers, N Hartmann, L Baeriswyl, S Bajaj, ... The Journal of Molecular Diagnostics 14 (1), 12-21, 2012 | 2 | 2012 |
| Brain-specific angiogenesis inhibitor 1 (BAI1) antibodies and uses thereof R Getts, J Bowers, ME George-Weinstein, J Gerhart US Patent 11,802,151, 2023 | 1 | 2023 |
| The immunomodulating enzyme indoleamine 2, 3-dioxygenase 2 (IDO2) as a target for therapy in autoimmune disease LMF Merlo, J Bowers, T Stefanoni, GV Gordon, R Getts, L Mandik-Nayak The Journal of Immunology 206 (1_Supplement), 66.01-66.01, 2021 | 1 | 2021 |
